Kaneez Fatima, Javeria Malik, Fariha Muskan, Ghana Raza, Areesha Waseem, Hiba Shahid, Syeda Fatima Jaffery, Umeed Khan, Muhammad Kashan Zaheer, Yasmeen Shaikh, Ahmed Mustafa Rashid
Human Psychopharmacology, 2024-07-31
OBJECTIVE: Despite the historical neurological use of Withania somnifera, limited evidence supports its efficacy for conditions like anxiety and insomnia.…
Sanjiv Kale, Adrian Lopresti, Ravleen Suri, Neha Garg, Deepak Langade
Journal of Psychoactive Drugs, 2024-11-05
This prospective, randomized, placebo-controlled study assessed the effects of Ashwagandha root extract (ARE) on cognition, energy, and mood in adults…
Background Ashwagandha (Withania somnifera) is an adaptogenic herb used to prevent and treat psychosomatic disorders. This systematic review and meta-analysis…
Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline, memory impairment, and behavioral alterations. The N-methyl-D-aspartate (NMDA)…
Cerebroside sulfotransferase (CST) is considered as therapeutic target for substrate reduction therapy (SRT) for metachromatic leukodystrophy (MLD). The present study…